Veru Inc (VERU)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $35.64M
Last updated: Nov 17, 2026 at 11:04 AM ET
Veru Inc (VERU) Competitors
The companies most similar to VERU are Verrica Pharmaceuticals (VRCA), Mural Oncology (MURA) and Mereo BioPharma Group PLC ADR (MREO). By market cap, VERU ranks 9th of the 13 companies on this page; Verrica Pharmaceuticals (VRCA) is the largest at $61.16M.
Peer Comparison
VERU's revenue growth of 18.3% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Veru (VERU) | $35.64M | N/A | N/A | 0.0% | N/A | 18.3% | 0.00% |
| Verrica Pharmaceuticals Inc (VRCA) | $61.16M | N/A | 3.0x | -189.2% | -496.2% | -51.8% | 0.00% |
| Mural Oncology plc (MURA) | $35.38M | N/A | N/A | 0.0% | -173.6% | 0.0% | 0.00% |
| Mereo BioPharma Group PLC ADR (MREO) | $49.11M | N/A | 61.3x | 0.0% | -116.6% | 0.0% | 0.00% |
| NanoViricides Inc (NNVC) | $31.41M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Biomea Fusion Inc (BMEA) | $42.31M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| RenovoRx Inc (RNXT) | $50.18M | N/A | 16.6x | 0.0% | N/A | 300.8% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Oncolytics Biotech Inc (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Instil Bio Inc. (TIL) | $41.23M | N/A | N/A | 0.0% | -11.9% | 0.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| iBio, Inc. Common Stock (IBIO) | $51.55M | N/A | 735.4x | 0.0% | N/A | 975.0% | 0.00% |
| Peer median | $41.77M | N/A | 39.0x | 0.0% | -145.1% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Veru, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Verrica Pharmaceuticals Inc (VRCA) | Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. | VRCA competitors |
| Mural Oncology plc (MURA) | Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors... | |
| Mereo BioPharma Group PLC ADR (MREO) | Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases... | MREO competitors |
| NanoViricides Inc (NNVC) | NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections. | NNVC competitors |
| Biomea Fusion Inc (BMEA) | Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat... | BMEA competitors |
| RenovoRx Inc (RNXT) | RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. | RNXT competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Oncolytics Biotech Inc (ONCY) | Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. | ONCY competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| Instil Bio Inc. (TIL) | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. | TIL competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| iBio, Inc. Common Stock (IBIO) | iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. | IBIO competitors |
Frequently Asked Questions About VERU
Who are VERU's main competitors?
The companies most similar to VERU include Verrica Pharmaceuticals (VRCA), Mural Oncology (MURA), Mereo BioPharma Group PLC ADR (MREO), NanoViricides (NNVC) and Biomea Fusion (BMEA), listed from the closest match.
Who is VERU's biggest competitor?
Verrica Pharmaceuticals (VRCA) is both the largest of the similar companies at $61.16M and the closest match by business profile, size, sector and industry.
How does VERU stock compare with its competitors?
VERU's net margin is 0.0% against a peer median of 0.0%.
Which of VERU's competitors pays a higher dividend?
VERU pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is VERU bigger than its competitors?
No. VERU is 9th by market cap among the 13 companies on this page; the largest is Verrica Pharmaceuticals (VRCA) at $61.16M.
VERU pages: Overview, Earnings, Forecast, Financials, Competitors